Cite
Biomarker-Guided Anti-Egfr Rechallenge Therapy in Metastatic Colorectal Cancer.
MLA
Ciardiello, Davide, et al. “Biomarker-Guided Anti-Egfr Rechallenge Therapy in Metastatic Colorectal Cancer.” Cancers, vol. 13, no. 8, Apr. 2021. EBSCOhost, https://doi.org/10.3390/cancers13081941.
APA
Ciardiello, D., Martini, G., Famiglietti, V., Napolitano, S., De Falco, V., Troiani, T., Latiano, T. P., Ros, J., Elez Fernandez, E., Vitiello, P. P., Maiello, E., Ciardiello, F., & Martinelli, E. (2021). Biomarker-Guided Anti-Egfr Rechallenge Therapy in Metastatic Colorectal Cancer. Cancers, 13(8). https://doi.org/10.3390/cancers13081941
Chicago
Ciardiello, Davide, Giulia Martini, Vincenzo Famiglietti, Stefania Napolitano, Vincenzo De Falco, Teresa Troiani, Tiziana Pia Latiano, et al. 2021. “Biomarker-Guided Anti-Egfr Rechallenge Therapy in Metastatic Colorectal Cancer.” Cancers 13 (8). doi:10.3390/cancers13081941.